UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000014037
Receipt number R000016349
Scientific Title Findings of Rheumascan in patients with rheumatoid arthritis and other arthritis-related diseases
Date of disclosure of the study information 2014/05/28
Last modified on 2019/03/30 20:51:10

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Findings of Rheumascan in patients with rheumatoid arthritis and other arthritis-related diseases

Acronym

Findings of Rheumascan in patients with rheumatoid arthritis and other arthritis-related diseases

Scientific Title

Findings of Rheumascan in patients with rheumatoid arthritis and other arthritis-related diseases

Scientific Title:Acronym

Findings of Rheumascan in patients with rheumatoid arthritis and other arthritis-related diseases

Region

Japan


Condition

Condition

rheumatoid arthritis and other diseases which can cause wrist or finger joint symptoms

Classification by specialty

Clinical immunology Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To explore findings specific to rheumatoid arthritis and other diseases by intra- and inter-disease (including healthy subjects) comparison of Rheumascan findings and to investigate usefulness of Rheumascan in differential diagnosis

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

1. signal intensity (semi-quantitative evaluation of the signal area in each joint region) and distribution of each joint
2. signal intensity and distribution outside the joint regions

Key secondary outcomes

1. Intra- and inter-disease comparison of Rheumascan findings at the enrollement and 3-6 months later.
2. relationship between rheumascan finidings and the diagnosis 3-6 months later in cases of undetermined diagnosis at the enrollment
3. relationship between Rheumascan findings and radiographic and ultrasonographic findings
4. safety of ICG administration in all cases


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Diagnosis

Type of intervention

Device,equipment

Interventions/Control_1

1. rheumascan examination at the enrollment
2. rheumascan examination 3-6 months after the enrollment (if a patient can be followed up 3-6 months later and written consent is obtained)
3. radiography and ultrasonography of hands at the enrollement and 3-6 months later if clinically indicated
4. clinical examination of both hands (skin and joint findings)

Interventions/Control_2

for healthy volunteers, only rheumascan examination and clinical examination are required

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients who can give written consent and fulfill either of the followings
1. 2010 ACR/EULAR RA classification criteria
2. connecitve tissue diseases other than rheumatoid arthritis
3. osteoarthritis, crystal-induced arthritis, complex regional pain syndrome
4. a patient suspected of having any of the above-mentioned diseases
5. healthy volunteers

Key exclusion criteria

1. contraindication of ICG (history of hypersensitive reaction to ICG or iodines)
2. pregnant or breastfeeding
3. a patient considered to be inappropriate for the study by the attending physician

Target sample size

110


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Masaaki Mori

Organization

Tokyo Medical and Dental University

Division name

Department of Lifetime Clinical Immunology

Zip code


Address

5-45, Yushima 1-chome, Bunkyo-ku, Tokyo

TEL

03-5903-4677

Email

mori.phv@tmd.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Fumio Hirano

Organization

Tokyo Medical and Dental University

Division name

Department of Lifetime Clinical Immunology

Zip code


Address

5-45, Yushima 1-chome, Bunkyo-ku, Tokyo

TEL

03-5803-4677

Homepage URL


Email

hirano.rheu@tmd.ac.jp


Sponsor or person

Institute

Tokyo Medical and Dental University

Institute

Department

Personal name



Funding Source

Organization

Department of Lifetime Clinical Immunology

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2014 Year 05 Month 28 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2014 Year 04 Month 30 Day

Date of IRB

2014 Year 01 Month 27 Day

Anticipated trial start date

2014 Year 05 Month 28 Day

Last follow-up date

2019 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2014 Year 05 Month 22 Day

Last modified on

2019 Year 03 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016349


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name